Intercellular adhesion mediators
CA 2084888 A1 · Owner: Perez, Mary S. · Inventors: Perez, Mary S.; Ratcliffe, Robert Murray; Gaeta, Federico C. A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to compositions and methods for reducing or controlling inflammation and for treating inflammatory disease processes and other pathological conditions mediated by intercellular adhesion. Compositions which selectively bind a selectin receptor and which have at least one selectin-binding moiety are provided by the present invention. The selectin-binding moieties have the general formula:, R1-Gal.beta.1,4(Fuc.alpha.1,3)GlcNAc-(R2)a wherein R1 is an oligosaccharide or R3-R4-C(CO2H)-, wherein R3 and R4 are the same or different and are -H -C1-C8 alkyl, -hydroxyl C1-C8 alkyl, -aryl C1-C8 alkyl or -alkoxy, C1-C8 alkyl; wherein R2 is .beta.l 3Gal, .alpha.1, 2Man or, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 14, 1991. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 14, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 14, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.